Cargando…
Reduced expression of exosomal miR-29s in peritoneal fluid is a useful predictor of peritoneal recurrence after curative resection of gastric cancer with serosal involvement
The peritoneal surface is the most frequent site of metastasis disease in patients with gastric cancer. Even after curative surgery and adjuvant chemotherapy, peritoneal recurrences often develop. Exosomes play pivotal roles in tumor metastasis via the transfer of microRNAs (miRNAs). In the present...
Autores principales: | Ohzawa, Hideyuki, Saito, Akira, Kumagai, Yuko, Kimura, Yuki, Yamaguchi, Hironori, Hosoya, Yoshinori, Lefor, Alan Kawarai, Sata, Naohiro, Kitayama, Joji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057811/ https://www.ncbi.nlm.nih.gov/pubmed/32323853 http://dx.doi.org/10.3892/or.2020.7505 |
Ejemplares similares
-
Exosomal microRNA in peritoneal fluid as a biomarker of peritoneal metastases from gastric cancer
por: Ohzawa, Hideyuki, et al.
Publicado: (2019) -
MiR-29b may suppresses peritoneal metastases through inhibition of the mesothelial–mesenchymal transition (MMT) of human peritoneal mesothelial cells
por: Kimura, Yuki, et al.
Publicado: (2022) -
Intraperitoneal transfer of microRNA‐29b‐containing small extracellular vesicles can suppress peritoneal metastases of gastric cancer
por: Kimura, Yuki, et al.
Publicado: (2023) -
Intraperitoneal Administration of Paclitaxel Combined with S-1 Plus Oxaliplatin as Induction Therapy for Patients with Advanced Gastric Cancer with Peritoneal Metastases
por: Saito, Shin, et al.
Publicado: (2020) -
Altered intraperitoneal immune microenvironment in patients with peritoneal metastases from gastric cancer
por: Takahashi, Kazuya, et al.
Publicado: (2022)